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Background:MicroRNA-155 is a proinflammatory small RNA, but its function in pathological angiogenesis is unknown.
Results:MicroRNA-155 deficiency increases angiogenic protein CCN1 expression, which harnesses retinal neovascularization
by reducing both microglia activation and inflammation.
Conclusion: The microRNA-155/CCN1 regulatory axis regulates angiogenic and inflammatory responses in the retina.
Significance: Modulation of microRNA-155 and CCN1 interaction is potentially beneficial in retinal neovascularization
therapy.
The response of the retina to ischemic insult typically leads to
aberrant retinal neovascularization, a major cause of blindness.
The epigenetic regulation of angiogenic gene expression by
miRNAs provides new prospects for their therapeutic utility in
retinal neovascularization. Here, we focus on miR-155, a
microRNA functionally important in inflammation, which is of
paramount importance in the pathogenesis of retinal neovascu-
larization. Whereas constitutive miR-155-deficiency in mice
results in mild vascular defects, forced expression of miR-155
causes endothelial hyperplasia and increases microglia count
and activation. The mouse model of oxygen-induced retinopa-
thy, which recapitulates ischemia-induced aberrant neovessel
growth, is characterizedby increased expressionofmiR-155 and
localized areas of microglia activation. Interestingly, miR-155
deficiency inmice reducesmicroglial activation, curtails abnor-
mal vessel growth, and allows for rapid normalization of the
retinal vasculature following ischemic insult. miR-155 binds to
the 3-UTR and represses the expression of the CCN1 gene,
which encodes an extracellular matrix-associated integrin-
binding protein that both promotes physiological angiogenesis
and harnesses growth factor-induced abnormal angiogenic
responses. Single CCN1 deficiency or double CCN1 and miR-
155 knock-out in mice causes retinal vascular malformations
typical of faulty maturation, mimicking the vascular alterations
ofmiR-155 gain of function. During development, themiR-155/
CCN1 regulatory axis balances the proangiogenic and proin-
flammatory activities of microglia to allow for their function as
guideposts for sprout fusion and anastomosis. Under ische-
mic conditions, dysregulated miR-155 and CCN1 expression
increases the inflammatory load and microglial activation,
prompting aberrant angiogenic responses. Thus, miR-155 func-
tions in tandemwith CCN1 tomodulate inflammation-induced
vascular homeostasis and repair.
The etiology of numerous vision-threatening ocular diseases,
such as retinopathy of prematurity and proliferative diabetic
retinopathy, is an aberrant response to injury of the retinal vas-
cular network that palliates themetabolic and oxygen demands
of the neural retina (1, 2). Indeed, the vascular beds supplying
the retina often sustain injury as a result of diabetes, trauma,
hyperoxia, aging, dyslipidemia, or the interaction of genetic
predisposition, environmental insults, and age. These injurious
stimuli commonly lead to an arrest of vascular development,
vaso-obliteration, and/or vascular occlusion. The subsequent
pathological response generates disorganized, leaky, and tortu-
ous vessels that leak into the interface between the vitreous and
the retinal tissue, attracting fibroglial elements causing severe
hemorrhage, retinal detachment, and vision loss.
New therapeutic strategies that are currently receiving
increasing attention focus on novel mechanisms regulating
normal and abnormal vessel growth bymicroRNAs (miRNAs),3
a relatively abundant class of gene expression regulators that
promote degradation ofmRNAsor prevent translation of target
genes (3, 4).More than 250miRNAs are reportedly expressed in
the retina, andmiRNAgene regulation has been shown to affect
retinal development, function, and diseases (5). Dicer and
Drosha, the RNase III endonucleases involved in miRNA gen-
eration, significantly affect angiogenesis during development,
and numerous studies suggest that miRNA function becomes
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more pronounced in response to pathophysiological stresses (6,
7). Specific functions have recently been attributed to individ-
ual endothelial cell-specific miRNAs, although a challenge still
remains in validating their relevance in pathological angiogen-
esis (8, 9). However, normal and abnormal growth of blood
vessels occurs through the interactions of vascular and non-
vascular cells, including parenchymal, neuronal, and immune
cells (10, 11). Therefore, a major focus must be placed on mas-
ter regulator miRNAs that are able to define how different cell
types interact and assemble to form the distinct characteristics
of normal and abnormal blood vessel types. This study demon-
strates that one such master regulator miRNA is miR-155.
miR-155 is a multifunctional miRNA that has been impli-
cated in various physiological and pathological processes,
including hematopoietic lineage differentiation, immunity,
inflammation, viral infections, cancer, and cardiovascular dis-
eases (12). miR-155maps within and is processed from an exon
of a noncoding RNA transcribed from the B-cell integration
cluster located on chromosome 21 (13). The B-cell integration
cluster shows strong sequence homology among humans,mice,
and chickens and is highly, although not exclusively, expressed
in lymphoid organs, implying an evolutionarily conserved func-
tion. Consistent with its widespread expression pattern inmye-
loid and lymphoid cells, miR-155 was reported to function in
hematopoiesis and the immune response. Mice deficient in
miR-155 showed clear defects in lymphocyte development and
generation of B- and T-cell responses in vivo and an impaired
antigen presenting function of dendritic cells (14, 15). Recent
studies have shown thatmiR-155 is also overexpressed in endo-
thelial cells, synovial fibroblasts, and monocytes of rheumatoid
joints and during the course of inflammation (16, 17, 18). Thus,
miR-155may play important role(s) inmediating inflammatory
and immune responses that are of paramount importance in
pathological angiogenesis. A study by Neilsen et al. (19) assem-
bled a comprehensive list of 140 miR-155 mRNA targets that
were experimentally confirmed by both the demonstration of
endogenous transcript regulation by miR-155 and validation of
the miR-155 seed sequence through a reporter assay. This list
included regulatory proteins formyelopoiesis and leukemogen-
esis (AICDA, ETS1, JARID2, SPI1, etc.) and inflammation
(BACH1, FADD, IKBKE, INPP5D, MYD88, RIPK1, SPI1, and
SOCS) and known tumor suppressors (C/EBP, IL17RB,
PCCD4, TCF12, ZNF652, etc.). This large number of miR-155
targets probably regulates miR-155 function in numerous bio-
logical processes in a context- and tissue type-dependent
manner.
Here we provide unprecedented evidence linking miR-155
expression or lack thereof to postnatal retinal vascular develop-
ment in vivo and abnormal retinal vessel growth in the mouse
model of OIR. The antiangiogenic functions of miR-155 corre-
late with the repression of CCN1, a secreted cysteine-rich and
integrin-binding matricellular protein that positively regulates
angiogenic signaling either directly by modulating endothelial
cell function and behavior through integrin binding or indi-
rectly by fine tuning the activity of growth factor receptors,
such as vascular endothelial growth factor (VEGF) receptor (20,
21). We report for the first time how miR-155-dependent sup-
pression ofCCN1 regulates both physiological and pathological
angiogenesis, at least in part, by modulating the inflammatory
response of the retina. The genetic, biochemical, and cell bio-
logical data support a model in which negative regulation of
CCN1 expression by miR-155 affects retinal vessel patterning
and normal growth through alteration of the function and acti-
vation of microglia, the resident inflammatory cells of the ret-
ina. Concordantly, the miR-155/CCN1 regulatory axis is a key
driver for the neuroinflammatory responses associated with
physiological and pathological angiogenesis.
Experimental Procedures
Mice—Wild-type mice on a C57BL/6 genetic background
(Jackson Laboratory) were bred and housed in the Department
of ComparativeMedicine at SUNYDownstateMedical Center.
Mice deficient in miR-155, miR-155/, and the Tg(UBC-cre/
ERT2)1Ejb transgenic line have been described previously (22,
23). Generation of CCN1flox/flox mice was described previously
(24). All animal studies were carried out in accordance with the
recommendations in the Guide for the Care and Use of Labo-
ratory Animals of the National Institutes of Health. The proto-
col was approved by the Committee on the Ethics of Animal
Experiments of the State University of New York Downstate
Medical Center.
Generation of CCN1 Conditional Allele and CCN1/miR-
155 Double Knock-out Mice—Mice with inducible deletion
of CCN1 in all tissue types were generated by cross-breeding
CCN1flox/flox with Tg(UBC-cre/ERT2)1Ejb mice to produce
CCN1flox/UBC-Cre/ and CCN1flox/UBC-Cre/ mice.
The latter were further crossed among each other or with
CCN1flox/flox to produce CCN1flox/UBC-Cre/, CCN1flox/
UBC-Cre/, or CCN1flox/floxUBC-Cre/ mice. A solution of
4-hydroxytamoxifen (4HT) was dissolved in ethanol at 10
mg/ml, and then 4 volumes of sunflower seed oil were added.
Samples of 4HT were thawed and diluted in sunflower seed oil
prior to intraperitoneal injection of 100 l to mouse pups. Lac-
tating mothers were alternatively given a single daily injection
of 4HT (2mg) to increase recombination efficiency (25). Geno-
typing was determined by polymerase chain reaction (PCR) to
identify mice with floxed alleles, hemizygous floxed allele and
Cre allele (CCN1/), and homozygous floxed alleles and one
Cre allele (iCCN1/). Recombination levels in CCN1/
mice as compared with CCN1/ were determined as
described previously (24). In addition, CCN1flox/floxUBC-
Cre/mice were bred withmRNA-155/mice to generate
heterozygous miR-155//CCN1/floxUBC-Cre/ mice.
Heterozygous mice were then intercrossed to generate
homozygous miR-155//CCN1flox/floxUBC-Cre/ mice,
which were further injected with 4HT to produce miR-155//
iCCN1/ double knock-out mice.
Quantification of Junctional Density, Length, and Migration
of Retinal Vessels during Development—Mouse eyes were col-
lected at the indicated postnatal days and fixed in 4% parafor-
maldehyde for 2 h. Retinas were dissected and laid flat on
SuperFrost Plus-coated slides to obtain whole mount prepa-
rations. Retinalmountswere then permeabilized in 0.1%Triton
X-100 at room temperature for 20min. Stainingwas performed
with Isolectin B4 (IB4), as described previously (26). Fields of
view of the retinal vascular networks from control and mutant
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mice were captured by using the 40 objective lens and
included regions of capillary-sized vessels directly adjacent to
radial arterioles (27). Vascular parametersweremeasured using
the AngioTool software (28). By assessing the variation in fore-
ground and background pixel mass densities across an image,
the software determinesmorphological and spatial parameters,
including the overall size of the vascular network, the total and
average vessel length, and vessel junctional density. For each
parameter, at least four fluorescent images/retina were taken
from 4–5 mice. The data are presented as means  S.E. The
statistical significance of differences among mean values was
determined by one-way analysis of variance and two-tailed t
test.
Intravitreal Injections—In order to assess the effect of Syn-
miR-155, mice were given a 1-l intraocular injection of 5
mol/l experimental Syn-miR-155 mimetic (Qiagen) in one
eye and 5 mol/l control miRNA in the other eye. Mice were
sacrificed at the indicated times, and retinas were dissected and
analyzed as described above. For gene therapy studies, a lenti-
viral vector (1 l) was injected into the vitreous in one eye of
each animal using a 33-gauge needled syringe. In the contralat-
eral eye, an equal volume of control vector (lnv-luc) was
injected. Cells infected with lnv-green fluorescent protein at a
multiplicity of infection of 5–10 units achieved transduction
efficiency of 70–90%, as determined by counting the number of
GFP-positive cells (26). For siRNA-mediated CCN1 suppres-
sion studies, siR-CCN1 or scrambled control siRNA was
administered at postnatal day 12 (P12) by intravitreal injection
behind the ora serrata and directly into the vitreal cavity. At
P17, all animals were euthanized and enucleated, and retinas
were processed for further analyses. No untoward effects (e.g.
redness or opacity) were noted from the intravitreal injections.
Oxygen-induced Retinopathy and Retinal Neovasculariza-
tion Image Analyses—Ischemic retinopathy was produced in
C57BL/6Jmice, as described by Smith et al. (29). Neonatalmice
and their nursing dams were exposed to 75% oxygen in a
PRO-OX 110 chamber oxygen controller from Biospherix Ltd.
(Redfield, NY) between P7 and P12, producing vaso-oblitera-
tion and cessation of vascular development in the capillary beds
of the central retina. On P12, the mice were placed at room air
until P17, when the retinaswere assessed formaximumneovas-
cular response. For developmental studies, room air mice were
raised under normal light and temperature conditions. Mice
were sacrificed at the indicated times after birth by CO2 eutha-
nasia and cervical dislocation or by decapitation. Eyes were
enucleated and the vascular phenotype of the retinas was ana-
lyzed as described above.
Quantification of vascular obliteration, retinal vasculariza-
tion, and preretinal neovascular tufts was performed at P12
and/or P17. The area of vascular obliteration was measured by
delineating the avascular zone in the central retina and calcu-
lating the total area using Photoshop CS5 (Adobe) software.
Similarly, the area of preretinal neovascularization was calcu-
lated by selecting tufts, which appear more brightly stained
than normal vasculature, based on pixel intensities. Selected
regions were then summed to generate the total area of neovas-
cularization. The avascular areas and zones of neovasculariza-
tion were expressed as a percentage of the total retinal surface
area.
Isolation of Small RNA andMicroRNA Arrays—Small RNAs
were isolated using the miRNeasy minikit (Qiagen) in accord-
ance with the manufacturer’s instructions. A total of 5 g of
small RNAs pooled from five experimental and five control ret-
inas of age-matched mice reared in room air was used for
microarray analysis. RNA samples were diluted to a concentra-
tion of 400 ng/l and reverse transcribed using the MiScript II
RT kit (Qiagen). miRNA profiling was performed with an miR-
Nome miScript miRNA PCR array plate in combination with
the miScript SYBR Green PCR kit (Qiagen), which contains
miScript universal reverse primer and QuantiTect SYBR PCR
master mix. The miRNA PCR array plate (Qiagen) includes
primers for 84maturemiRNAs and controls. RNU6-2 served as
an internal normalizer. Amplification was performed using an
ABI 7900 real-time PCR machine (Applied Biosystems). Spec-
ificity and identity were verified by dissociation curve analysis.
Baseline and threshold were set automatically for all PCR runs.
Threshold cycle (Ct) values were exported as an Excel file for
further analyses. Data quality control was reviewed to ascertain
the PCR reproducibility and reverse transcription efficiency
and detect genomic DNA contamination in amplified samples
of both groups.
Bromo-2-deoxyuridine (BrdU) Incorporation Assay—BrdU
was administered at 10mg/kg intraperitoneally at P5. For BrdU
labeling, retinas were digested with Proteinase K (10 g/ml),
fixed in 4% paraformaldehyde, treated with DNase I (0.1 units/
ml) for 2 h at 37 °C, and incubatedwith anti-BrdU antibody (BD
Pharmingen). Endothelial Cells were visualized by stainingwith
isolectin B4 A568 (Molecular Probes), and BrdU was detected
using directly conjugated mouse anti-BrdU Alexa 488 (Molec-
ular Probes). The number of BrdU-positive cells per surface
unit in equivalent areas of retinas from control and mutant
mice was determined.
Immunohistochemistry andWestern Immunoblotting—Fixed
and permeabilized retinal mounts were stained with Isolectin
B4 (IB4) as described above and/or with Iba-1 (Wako), glial
fibrillary acidic protein (GFAP) (Invitrogen), and Collagen IV
(EMDMillipore). Immunodetectionwas performedwith either
rhodamine- or fluorescein-conjugated anti-mouse or anti-rab-
bit secondary antibody diluted in blocking solution. Retinal
mounts werewashed several times in phosphate buffer solution
between incubations. Images were acquired using a Leica
DM5500B fluorescence microscope (Leica).
For retinal protein analysis, mouse eyes were enucleated, and
retinaswere carefully dissected and homogenized in lysis buffer
containing 10 mM NaF, 300 mM NaCl, 50 mM Tris, pH 7.4, 1%
Triton X-100, 10% glycerol, and 1 mM EDTAwith a 1% volume
of phosphatase and protease inhibitormixture. Protein samples
(25 g) were fractionated in 10% SDS-polyacrylamide gel and
transferred to nitrocellulosemembrane, andWestern blot anal-
ysis was performedwith each of the following primary antibod-
ies: CCN1 (30), CD68 (Bio-Rad), and glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) (Aviva Systems Biology).
Immunodetection was performed using enhanced chemilumi-
nescence (Pierce). Protein bands were quantified by ImageJ
(National Institutes of Health).
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Isolation and Quantitative Analysis of mRNAs—Total RNA
was extracted from cells or tissues using the RNeasy column
purification protocol (Qiagen). Quantitative analysis by qPCR
was performed to determine the levels of a specificmRNAusing
TaqMan technology (Applied Biosystems). Highly specific
primers were designed using Primer3, a Web-based primer
design program. The cycling parameters for qPCR amplifica-
tion reactionswere as follows: AmpliTaq activation 95 °C for 10
min, denaturation 95 °C for 15 s, and annealing/extension 60 °C
for 1 min (40 cycles). Triplicate Ct values were analyzed with
Microsoft Excel using the comparative CT (Ct) method as
described by themanufacturer (Applied Biosystems). The tran-
script amount (2Ct) was obtained by normalizing to the
acidic ribosomal phosphoprotein, an endogenous reference
that has been shown to be the housekeeper gene least sensitive
to oxygen tension in animal models of OIR (31).
Cell Culture—In vitro studieswere performedwith rat retinal
endothelial cells (Cellpro Labs) and maintained in culture
according to the manufacturer’s instructions. Cells were prop-
agated in 35-mm dishes in predefined endothelial growth
medium containing 10% fetal bovine serum (FBS) (Atlanta Bio-
logical Inc.). Cells at 80% confluence were treated as described
in the text and further processed for various analyses.
Transient Transfection, Mutagenesis, and Reporter Assay—
Cultured cells were plated at a density of 1 105/cm2 in 35-mm
dishes and maintained in serum-containing medium for 18 h.
Transfection was then performed using Lipofectamine 2000
transfection reagent in serum-free medium according to the
manufacturer’s specifications (Invitrogen). Cells were allowed
to recover for 16 h in fresh medium containing 10% serum. To
assess the functionality of the 3-UTR of CCN1, full-length
CCN1 3-UTR (U690) was cloned downstream of the Gaussia
luciferase reporter in the plasmid pEZX. The plasmid pEZX
with no 3-UTR (MT05) (Genecopeia) was used as a negative
control.Additional reporter constructs used includepEZXcon-
structs with serial truncations of the CCN1 3-UTR, leaving
only 548 (U548)- and 229 (U229)-nucleotide-long 3-UTRs.
Additionally, U690 containing mutations in putative miR-155
and/or miR-181 seed sequences were generated by site-di-
rected mutagenesis (Genescript) and used in transfection
experiments as well. Constructs were fully sequenced in both
directions to confirm successful mutagenesis before use. Cells
were co-transfected with pCMV-Cluc2 vector (New England
Biolabs) containing the Cypridina luciferase gene to adjust for
transfection efficiency. The Lipofectamine 2000:DNA mixture
plus serum-free medium was left on cells for 3 h. Cells were
then allowed to recover in freshmedium containing 10% serum
for 16 h and further incubated in serum-free medium.Medium
samples were collected at different time periods and assayed for
luciferase activities as both Gaussia and Cypridina luciferases
were secreted in the medium. Luciferase activity was measured
in a 20/20 Luminometer (Turner Biosystems) using the BioLux
assay system (New England Biolabs) as per the manufacturer’s
instructions. Each experiment was performed at least three
times in triplicate, and all experiments included a negative con-
trol (MT05). The latter served as a baseline indicator of lucifer-
ase activity.
Statistical Analyses—Statistical analyses were performed
using Prism for Windows version 4 from GraphPad Inc. (San
Diego, CA). To test differences among several means of signif-
icance, a one-way analysis of variance with the Newman-Keuls
multiple comparison test was used. Where appropriate, a post
hoc unpaired t test was used to compare two means/groups,
and p values of 	0.05 or 	0.01 were considered significant.
Student’s t test with Bonferroni correction was used for pair-
wise comparisons when an analysis of variance (p) value was
statistically significant.
Results
MicroRNA Expression Profile in the Retina of OIRMice—We
used themousemodel ofOIR, an ischemia-induced retinal neo-
vascularization model, to identify potential master regulator
miRNAs of vascular loss and neovascular growth. First, we per-
formed miRNA array profiling of 84 miRNAs that have been
assigned a role in vascular function and/or dysfunction. Over-
all, microarray results shown in Table 1 were concordant with
previous surveys of themiRNA expression pattern in the retina
using either microarrays or deep sequencing technologies (5,
32). Several miRNAs with stricter cut-off criteria (log2 
2 or
	2) were differentially expressed at P12 following hyperoxia-
induced vaso-obliteration, including miR-103, miR-107, miR-
125, miR-126, miR-155, miR-93, miR-16, and miR-195. Real-
time PCR-based validation of the expression of severalmiRNAs
confirmed the array result trends (Fig. 1A). Further analyses
showed thatmiR-155was consistently increased following both
hyperoxia at P12, representing the vaso-obliterative phase
(phase 1), and ischemia at P17, signifying the neovasculariza-
tion phase (phase 2), of this model (Fig. 1B). The levels of miR-
155 were consistently elevated at every time point during phase
1 and phase 2 (2.4- and 4.2-fold, respectively) as compared with
normoxic conditions (Fig. 1B). Thus, miR-155 levels were up-
regulated under conditions causing vascular alterations or
remodeling.
Vascular Alterations Associated with miR-155 Expression or
Deficiency in the Retina—To examine the role of miR-155 in
retinal vascular obliteration and repair, we subjected wild-type
and mi-R155/ mouse pups to OIR and compared their vas-
cular patterns. miR-155-deficient mice did not display any
gross anatomical abnormalities and showed normalMendelian
inheritance as reported previously (23). Exposure to hyperoxia
(P7 to P12) resulted in vaso-obliteration of the central superfi-
cial capillary plexus (Fig. 2A, a–d). In both wild-type and miR-
155/ mice, nearly 32% of the retinal surface area was vaso-
obliterated (Fig. 2C). However, miR-155/ mice exhibited a
rapid revascularization of avascular areas during the subse-
quent normoxic phase (Fig. 2B, a–d). More than 95% of the
retinal surface was vascularized in miR-155-deficient mice as
compared with only 87% in wild-type mice (Fig. 2D). In miR-
155/ mice, the retinal vasculature exhibited normal mor-
phology and branching in the mid-peripheral and peripheral
regions except for sparse areas around the optic nerve. Simi-
larly, preretinal neovascular tufts, which can be seen abun-
dantly in the central and mid-peripheral retina in wild-type
mice, were minimally present (	2% of the retinal surface), and
in many cases, they were undetectable in miR-155-deficient
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mouse retinas (Fig. 2E). Thus, although miR-155 deficiency
provided no protective effect against hyperoxia-induced
vasoobliteration, it allowed rapid revascularization and/or
normalization of the retinal vasculature during the ischemic
phase of OIR and prevented the development of aberrant
neovascularization.
To determine whether the vascular response to ischemic
injury stems from developmental vascular alterations, we
examined the net effect of miR-155 deficiency on postnatal ret-
inal vessel development. In wild-type mice, vascularization of
the outer retina begins at P0 from the central retinal artery, and
endothelial cells sprout to reach the peripheral region at about
P8-P9. Retinas from miR-155/ mice did not show overt
defects in vessel growth and specification in arteries, capillaries,
and veins (Fig. 3A). However, quantitative assessments of
angiogenesis at P3 and P9 by computing several morphometric
parameters showed a significant decrease of the junctional den-
sity in miR-155/ retina as compared with wild-type control
(Fig. 3B). Conversely, vascular length was increased by more
than 40% in miR-155/mouse retinas, whereas total vascular
area was not significantly affected (Fig. 3, C and D), suggesting
that deletion of miR-155 mostly affected vascular density and
distribution.
Next, the effects of miR-155 gain of function in mice were
examined through intravitreous injection of a miR-155 mimic
(Syn-miR-155). Syn-miR-155 was injected within the vitreous
at P3 in wild-type mice during the active growth of the super-
TABLE 1
Summary of differentially expressed miRNAs in the retina following
hyperoxia
Data were filtered by -fold change
2 or	2 and p	 0.05.
FIGURE 1. Differential expression of miR-155 in the retina following
hyperoxia-induced vasoobliteration and subsequent vascular re-
modeling. A, C57BL/6micewere placed in 75%oxygen at P7 and returned
to room air at P12. Mice were sacrificed at P12 and P17. Small RNA species
were isolated and reverse transcribed into cDNA, and real-time reverse
transcription PCR was used to determine the levels of miR-93, miR-16,
miR-195, miR-125, and miR-155 relative to the levels of RNU6-2 at P12 and
P17. *, p 	 0.05 versus control. B, quantitative analysis of miR-155 in the
retina throughout the time course of hyperoxia and subsequent ischemia.
Themean threshold cycle numbers (Ct) for miR-155 were compared with
control non-hyperoxic non-ischemic retinas. *, p	 0.05. **, p	 0.001 (n
5). Error bars, S.E.
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ficial capillary plexus, and the vascular pattern was analyzed at
P6. As shown in Fig. 3E, Syn-miR-155 delayed migration of the
radially expanding superficial capillary plexus and hindered
advancement toward the retinal edge. Vessels of the Syn-miR-
155-injected pups only reached 59%of the distance to the retina
edge, compared with 80% in littermate controls injected with a
scrambled miRNA (Fig. 3F). In the retina, endothelial cells
sprout along GFAP-positive astrocytes that emerge from the
optic nerve head. GFAP staining indicated that astrocyte cov-
erage was not affected by miR-155 gain of function (Fig. 3G),
suggesting that the retinal endothelial cell sprouting evoked by
miR-155 mimic is not secondary to potential astrocyte growth
or migration. Interestingly, Syn-miR-155 induced hyperprolif-
eration of endothelial cells at the leading vascular edge with an
65% increase of BrdU-positive cells, whereas miR-155-defi-
ciency resulted in 20% reduction of endothelial cell prolifera-
tion as compared with wild-type littermates (Fig. 3, H and I).
Growing endothelial cells appeared to incorporate into pre-
formed vessels and no longer directed toward angiogenic
sprouts, resulting in thicker and denser vasculature. Taken
together, our results indicate that miR-155 modulates retinal
vessel growth and remodeling both during development and
under ischemic conditions.
miR-155 Represses CCN1 Gene Expression through Direct
Interaction with CCN1 3-UTR—To begin to elucidate the
mechanisms whereby miR-155 regulates retinal angiogenesis,
we used a bioinformatic approach to identify putative gene tar-
gets of miR-155. Among the predicted genes, we focused on
CCN1, a matricellular protein best known for its angiogenic
potential (11, 21). CCN1 is encoded by an inducible immediate-
early gene whose expression substantially increases during
postnatal development of the retinal vasculature in mice (33).
To determine whether in vivomiR-155 levels are inversely cor-
related to those of CCN1, we examined CCN1 gene expression
in the retina following intravitreal injection at P4 of the Syn-
miR-155 mimic in the mouse eye during the active postnatal
angiogenic process. As shown in Fig. 4, A and B, Syn-miR-155
reduced both CCN1 mRNA and protein levels below control
levels. Conversely, exposure ofmiR-155/mouse pups toOIR
increased CCN1mRNA and protein levels at P12 andmarkedly
at P17 compared with wild-type mice (Fig. 4, C and D). To test
whether enhanced expression of the endogenousCCN1 gene in
miR-155/ mouse retina contributed to the vascular pheno-
type followingOIR,mouse pup eyes were injected at P4 prior to
OIR with a lentiviral vector encoding a mutant form of the
CCN1 protein lacking the C-terminal domain. This mutant
variant acts as a dominant negative form of the wild type
protein and inhibits CCN1 activity (20). Retinal vessel sen-
sitivity to hyperoxia at P12 was not affected by injection of
lnv-CCN1-CT because the degree of vaso-obliteration was
similar to that of retinas from eyes injected with the control
vector (data not shown). However, OIR-induced neovascu-
larization was significantly increased by 48% in lnv-CCN1-
CT-injected eyes as compared with control vector-injected
ones (Fig. 4, E and F). In addition, the avascular area in the
retina was further increased following the loss of CCN1
activity in miR-155/mice (Fig. 4G), suggesting that CCN1
expression contributed to vascular regrowth in miR-155/
mice subjected to OIR.
To test whether miR-155 represses CCN1 expression
through direct interaction with the 3-UTR of the CCN1 gene,
we cloned the 3-UTR of CCN1 into a reporter plasmid down-
stream of a luciferase reporter gene driven by the SV40 pro-
moter (Fig. 4, H and I). Cells were transfected with this con-
struct, and a luciferase assay was performed to measure the
3-UTR activity. As shown in Fig. 4J, the activity of a luciferase
reporter fused to the 3-UTR of CCN1 (U690) was repressed as
compared with the empty reporter vector (MT05). According
to the TargetScan algorithm, the 3-UTR of CCN1 contains
highly conserved 7–8-mer target “seed” sequences for several
FIGURE 2. Effects ofmiR-155deletiononhyperoxia-induced retinal vaso-
obliteration and preretinal neovascularization following OIR. A and B,
representative flat mount preparations of IB4-stained retinas eyes at P12 (A)
and P17 (B) of wild-type (WT) (a) and miR-155-deficient (b) mice. Areas of
vaso-obliteration andpreretinal neovascular tuft formation as determinedby
computer-assisted image analyses are shown in yellow and blue, respectively
(c for a and d for b). C–E, compiled data showing percentage of avascular
(C andD) and neovascular tuft areas (E) inWT andmiR-155/mouse retinas.
**, p	 0.05 versusWT (n 6–8). Error bars, S.E.
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miRNAs, including miR-155, miR-22, miR-181, and miR-221
(Fig. 4H). Serial deletion of the CCN1 3-UTR showed that
removal of the distal 150-nucleotide sequence containing miR-
221/222 affected the reporter activity similarly as the removal of
the full-length 3-UTR. Deletion of the distal 230-nucleotide
sequence containing the highly conserved miR-181 seed
FIGURE 3. Effects of miR-155 expression and deficiency on retinal vessel growth and development. A, representative immunofluorescence images
of IB4-stained whole mount retinas at P3 and P9 of wild-type and miR-155/mice. Vascular parameters were analyzed using the AngioTool software.
The outline of the vasculature is shown in white, the vasculature skeleton representation is shown in red, and branching points are green (b for a, d for
c, f for e, and h for g). Note the strong and dense vascular network in wild-type compared with miR-155/mouse retinas. B–D, quantitative analysis of
vascular parameters of representative retinas of WT and miR-155/ mice. Graphical representations of the analysis of junction density (B), vascular
length (C), and vascular area (D) are shown. **, p 	 0.05 versus same age WT (n  5). E, effects of miR-155 mimics on retinal vascular development.
IB4-labeled vasculature of whole retinal mounts at P6 after Syn-miR-255 treatment at P3. Control mice were injected with scrambled control miRNA.
Parallel bars represent distance between the vascular front and the retinal edge. F, quantification of sprouting distance in wild-type mice injected with
control or Syn-miR-155. Vascular progression as a function of the retinal radius is shown. *, p	 0.05 versus control (Cntl) (n 4).G, IB4- and GFAP-labeled
whole retinal mounts of wild-type mice injected with scrambled miRNA or Syn-miR-155. Note that endothelial cell sprouting along GFAP-positive
astrocytes similarly occurred in control and Syn-miR-155-injected eyes. H, effects of miR-155 gain or loss of function on endothelial cell growth during
retinal vessel development. Whole mount retina images of BrdU incorporation (green) together with IB4 staining (red) at P6 of wild-type, Syn-miR-155-
injected, and miR-155/ mice. I, proliferation index at P6 was measured by counting BrdU-positive nuclei. Equivalent areas of retinas of scrambled
control miRNA-injected wild-type, Syn-miR-155-injected, and miR-155/ mice were analyzed. Data are means  S.E. (error bars). *, p 	 0.05; **, p 	
0.001 versus wild-type control (Cntl) (n  5).
Regulation of Retinal Angiogenesis bymiR-155/CCN1 Interaction
23270 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 38•SEPTEMBER 18, 2015
sequence reduced the activity by only 15%, suggesting that the
proximal 3-UTR region contains the essential functional
repressive elements. Site-directed mutagenesis of the miR-155
seed sequence located in the proximal region reduced the
repressive effects of the 3-UTR by 76% (Fig. 4K). Mutation of
both miR-155 and miR-181 seed sequences resulted in similar
repressive activity. Thus, miR-155 directly targets the CCN1
3-UTR, leading to repressed CCN1 gene expression.
FIGURE 4.MicroRNA-155 directly targets CCN1 gene expression during vessel and neovessel growth. A and B, effects of Syn-miR-155 injection on
CCN1 gene expression during retinal vessel development. CCN1 gene expression was determined at the mRNA (A) and protein level (B) in retinal tissue
lysates fromwild-typemice at P6 after treatment at P3with either scrambled control miRNA (Cntl) or Syn-miR-155. *, p	 0.05 (n 3). C andD, expression
of the CCN1 gene at the mRNA (C) and protein (D) levels in wild-type and miR-155-deficient mice following OIR. Wild-type and miR-155/mice were
placed in 75% oxygen at P7 and returned to room air at P12. Retinas were harvested at P12 or P17, and CCN1 expression was analyzed by either qPCR
or Western immunoblotting as described under “Experimental Procedures.” CCN1 mRNA levels were normalized to those of acidic ribosomal phospho-
protein. **, p	 0.01 versuswild type. ***, p	 0.001 versuswild type (n 5). GAPDH was used as a loading control of protein lysate analysis. E–G, effects
of CCN1 suppression on the vascularization and neovascularization of the retina of miR-155/mice following OIR. Whole mount retinas shown were
from eyes injected at P4 with either lnv-luc or lnv-CCN1CT encoding a dominant negative form of CCN1. Mice were subjected to OIR at P7. Areas of
vaso-obliteration and preretinal neovascular tufts at P17 as determined by computer-assisted image analyses are shown in yellow and blue, respectively
(E). Compiled data showing the percentage of neovascular and avascular areas in eyes injected with lnv-luc and lnv-CCN1CT are shown in F and G,
respectively. **, p	 0.01 versusmiR-155/ (n 5). H, schematic layout of the CCN1 3-UTR, with the relative location of miR-155, miR-22, miR-181, and
miR-221 binding sites. Depiction is not to scale. 3-UTR sequences of CCN1 of mouse, human, and chimpanzee and predicted interaction with conserved
miRNA seeds are shown. The sequence of the CCN1 3-UTR seed mutant used for reporter assays and predicted disruption of the miR-155 and miR-181
interactions are also shown. I–K, transient transfection of endothelial cells was performed with an empty plasmid (MT05) or pEZX-CCN1 3-UTR plasmids
with and without mutated miRNA sequences depicted in H. Luciferase activity assays were performed on the supernatant media as described under
“Experimental Procedures.” Gaussia luciferase values have been normalized to those of Cypridina luciferase, and the percentage of luciferase activity is
represented. **, p 	 0.05 versus U690. ***, p 	 0.001 versus MT05 (n  4). Error bars, S.E.
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Conditional Deletion of CCN1 Causes Retinal Vascular
Defects Similar to Those Caused bymiR-155Gain of Function—
We hypothesized that if modulation of CCN1 expression by
miR-155 plays a non-redundant role in retinal vascular devel-
opment and repair, loss ofCCN1will result in defective vascular
architecture and remodeling. To test this hypothesis, we have
generated a conditional null allele of CCN1 because constitu-
tive inactivation of the CCN1 gene leads to early embryonic
lethality (34). Mice carrying a loxP-flanked CCN1 gene
(CCN1flox/flox) were intercrossed with UBC-Cre-ERT2 trans-
genics, which ubiquitously express tamoxifen-inducible Cre
recombinase (Fig. 5A). UBC-CreERT2-mediated CCN1 dele-
tion effectively eliminated CCN1 gene expression because less
than 10% of CCN1 mRNA and less than 20% of residual CCN1
protein were detected in the retina following daily 4HT injec-
tion for 3 days (Fig. 5, B and C). At P4, retinas of iCCN1/
FIGURE 5. Inducible knock-out of the CCN1 gene recapitulates the retinal vascular abnormalities of miR-155 gain of function. A, schematic diagrams
showing the targeted CCN1genomic locuswith the CCN1 flox-neo allele, the CCN1 flox allelewith the neomycin resistance cassette deleted by recombination
with loxP sites, and the iCCN1/ locus following 4HT-induced Cre-mediated excision. B and C, CCN1mRNA (B) and protein (C) levels in retinal homogenates
of control CCN1/and iCCN1/mice. Retinaswereharvestedat P4 followingdaily injectionof 4HT startingat P1andanalyzed forCCN1expressionbyqPCR
and Western immunoblotting. **, p	 0.001 versus CCN1flox/flox. D–F, representative immunofluorescence images of IB4-stained flat-mount mouse retinas of
CCN1/, iCCN1/, miR-155/, and miR-155//iCCN1/ mice upon 4HT injection. G and H, analysis and quantification of vascular parameters of
representative retinas from CCN1/, iCCN1/, and miR-155//iCCN1/ mice at P5 using the AngioTool software. Fields of view at the sprouting
vascular front of the retinal vascular networks from control andmutantmicewere captured using a40 objective lens and included regions of capillary-sized
vessels directly adjacent to radial arterioles. Graphical representations of the analysis of the junctional density and vessel length are shown in G and H,
respectively. **, p	 0.01 versus CCN1/ (n 5). Error bars, S.E.
Regulation of Retinal Angiogenesis bymiR-155/CCN1 Interaction
23272 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 38•SEPTEMBER 18, 2015
mutant mice displayed increased vascularity per surface unit
but showed striking defects in the radial expansion of the vas-
cular plexus from the optic nerve head to the periphery (Fig.
5D). At P7, loss of CCN1 resulted in reduced forward progres-
sion of the superficial plexus and increased vascular anastomo-
sis at the front of the expanding vascular plexus (Fig. 5E). In
addition, iCCN1/mouse retinas showed widely lumenized
vessels with increased diameter, which was most severe close
to arteries and the vascular front. Vascular sprouts of wild
type mice were generally slender compared with those of
iCCN1/ mice, suggesting continued expansion of blood
vessels and reduced forward sprouting. This phenotype is strik-
ingly similar to that of endothelium-specific loss of CCN1 that
showed reduced forward progression of the superficial plexus
but increased speed of growth (35). To test the effects of com-
pound knock-out of CCN1 and miR-155, we generated miR-
155//iCCN1/mice in whichmiR-155 was constitutively
deleted whereas CCN1 alleles were conditional by initially inter-
crossing miR-155 mice with UBC-Cre-ERT2 CCN1flox/flox mice.
Administration of 4HT from P1 to P3 resulted in increased
vascularity, widening of blood vessels, and reduced lacunarity
of the retinal vasculature of miR-155//iCCN1/ mouse
pups (Fig. 5F). These alterations are reminiscent of the retinal
vascular phenotype following the loss of CCN1 alone (Fig. 5D).
Quantitative analyses of vascular parameters further evidenced
increased junctional density but a significantly reduced vessel
length average in both iCCN1/ and miR-155//
iCCN1/mouse retinas as comparedwithwild-type ormiR-
155/mouse retinas (Fig. 5,G andH). Thus, single deletion of
CCN1 or double knock-out of bothCCN1 andmiR-155 pheno-
copied, at least in part, the vascular phenotype of miR-155 gain
of function.
miR-155/CCN1 Regulatory Axis Modulates Microglial Cell
Behavior and Activation—Retinal microglial cells, the resident
ocular macrophages, are immunocompetent cells that respond
to inflammation and infection, phagocytosing debris produced
during normal physiological remodeling or degenerative dis-
eases (36). Microglia-deficient mice were found to have
reduced numbers of vascular branch pointswith fewer points of
contact between neighboring tip cells in the retina, suggesting
that microglia provide scaffolds for sprout fusion and anasto-
mosis (37). BecausemiR-155 deletion induced the formation of
a sparser vascular networkwith lengthier vessels whereas either
gain of miR-155 function or CCN1 deletion abnormally
enhanced vessel anastomosis, we hypothesized that miR-155
and CCN1 affect microglia function and behavior. During
development, retinal microglia enter the retina from the
peripheral margins via the blood vessels of the ciliary body as
well as centrally from the embryonic hyaloid artery at the optic
nerve head and vitreous (38). Superficial microglial cells are
found within the inner plexiform layer in which their density is
the highest, the retinal ganglion cell layer, and the nerve fiber
layer, whereas deeper microglial cells reside within the outer
plexiform layer. In P4 wild-type mouse retinas, Iba-1 micro-
glia occupy the entire retinal surface, including both vascular
and avascular areas (Fig. 6, A and B). However, microglia were
sparsely present, and their number was significantly reduced
(15%) inwhole retinalmounts ofmiR-155/mice compared
with those of wild-type mice (Fig. 6, A and D), suggesting an
early loss of microglia as a result of miR-155 deletion. Con-
versely, loss of either CCN1 alone or both miR-155 and CCN1
was associated with a 35% increase in the number of microglia
when compared with wild-type mouse retinas. As sprouting
angiogenesis occurs, retinal microglial cells are commonly
found at sites of contact between neighboring endothelial tip
cells bridging vascular sprouts to add new circuits to the exist-
ing vessel network (Fig. 6B). In the largely anastomosed retinal
vasculature of iCCN1/ and miR-155//iCCN1/
mice, microglia were frequently positioned at branching points
of the excessively anastomosed superficial capillary plexus (Fig.
6C). Thus, single or double knock-out of CCN1 and miR-155
alter both microglial cell number and retinal vascularity.
We further examined the effects of ischemia on microglial
cells following loss of miR-155 alone or in combination with
CCN1. Incidentally, miR-155//iCCN1/ mouse pups
abruptly died following exposure to hyperoxia. Mice with com-
pound deletion of miR-155 and CCN1 appeared normal and
active during exposure to hyperoxia, and their sudden death
occurred within 1 or 2 days under normoxia. It is possible that
following hyperoxia, double knock-outmice died of respiratory
failure, a common pulmonary complication associated with
hyperoxic conditions (39). Pulmonary insufficiency may have
occurred as a result of dampened inflammatory response from
miR-155 loss together with accelerated lung epithelial cell
death previously shown to be associated with loss of CCN1
expression in the lung (40). To circumvent the premature death
of miR-155-CCN1 double knock-out mouse pups following
hyperoxia, we induced local suppression of CCN1 through
intravitreal injection of CCN1-siRNA (siR-CCN1) in miR-
155/ mice. Small inhibitory RNAs have been used success-
fully to selectively inhibit gene expression in the retina (41, 42).
As shown in Fig. 7, A and B, loss of miR-155 promoted a near
normalization of the vasculature after OIR. However, miR-
155//siR-CCN1mouse retinas exhibited vascular alterations
similar to those of wild-type OIR animals with persistence of
avascular areas in the central retina and the appearance of neo-
vascular tufts (Fig. 7, A–C). In miR-155//siR-CCN1 mice,
retinal vessels of the superficial capillary plexus appeared highly
anastomosed with enlarged lumen, which is reminiscent of
developing vessels in CCN1-deficient mouse retinas (Fig. 7C).
Microglial cell count was determined following OIR in repre-
sentative field areas of the peripheral vascularized zone, central
avascular zone, and mid-retinal neovascularized zone. In wild-
type OIRmice, the numbers and distribution of microglial cells
in the central zone were similar to those in the peripheral zone
(Fig. 7, D and E). However, the number of microglial cells sig-
nificantly increased in the neovascular areas in which IB4 and
Iba-1 cells were densely packed within and in close proximity
to neovascular tufts. InmiR-155-deficient OIRmice, microglial
cell counts were relatively uniform in all three zones of whole
retinal mounts concomitantly with a visibly normalized retinal
vasculature (Fig. 7, F and G). Conversely, loss of both miR-155
and CCN1 recapitulated microglia distribution and count
obtained in wild-type OIR mice in zones 1, 2, and 3 (Fig. 7, H
and I), suggesting that CCN1 is, at least in part, responsible for
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microglial cell-dependent alterations of the retinal vasculature
during OIR.
Typical resting Iba-1 microglial cells commonly exhibit a
ramified morphology with a small ovoid or triangular body
from which three or four primary processes have sprouted and
then divided dichotomously into secondary ones. These cells
respond to ischemic stress and injurious stimuli by adopting an
activated state characterized by alterations in cellularmorphol-
ogy and function, tissue distribution, migration, proliferation,
and expression of various cytokines and growth factors. Micro-
glial cells at the advancing ischemic retinal vascular edge
adopted an activated state by retracting their processes and
becoming lectin-positive in wild-type mice following injection
of either control or Syn-miR-155 (Fig. 8A). Microglia with a
similar morphology and activation features were found in reti-
nal mounts of CCN1-deficient mice (data not shown). Loss of
miR-155was associatedwith a slight decrease ofCD68, a single-
chain heavily glycosylated protein of 90–110 kDa that is
expressed on the lysosomal membrane of active retinal micro-
glial cells (Fig. 8,E and F). However, CCN1 deletion alone or in
combination with miR-155 deletion significantly increased
CD68 protein levels as compared with those in the corre-
sponding control mouse retinas. In normoxic controls, den-
dritic-like microglial cells ran parallel to the retinal surface
and were located in perivascular areas in the peripheral ret-
ina (Fig. 8B). Conversely, active microglial cells were found
in higher numbers around the vascular tufts between the
central avascular and peripheral vascularized zones in P17
OIRmouse retinas (Fig. 8C, a and b). Morphologically, active
cells largely found in the superficial layers retracted their
processes and became IB4-positive (Fig. 8C, c), whereas
those in the deeper layers exhibited a normal resting mor-
phology (Fig. 8C, d), suggesting that the formation of vascu-
lar tufts occurs in the midst of activated neighboring super-
ficial microglia. Conversely, resting ramified microglia were
also found around the normalized retina of miR-155/
mice after OIR (Fig. 8D). As shown in Fig. 8, E–G, CD68
protein levels were reduced in retinal lysates of miR-155/
OIR mice, but their levels were significantly increased in
retinal lysates of miR-155//siR-CCN1 mice as compared
with those of wild-type OIR mice. Thus, loss of CCN1
increasedmicroglial cell activation in the retinas both during
development and under ischemic conditions.
Regulation of Microglial Marker and Inflammatory Cytokine
Expression via miR-155 and CCN1—We determined the
expression of a battery ofmicroglialmarkers in retinal lysates of
miR-155/ andCCN1/mice and examined a potential cor-
relation of their levels with that of a panel of key inflammatory
cytokines that have been functionally linked to microglia acti-
vation and angiogenesis. As shown in Fig. 9A, the expression of
FIGURE 6.Altered retinal microglial cell abundance, distribution, and activation inmiR-155- and/or CCN1-deficientmice. A and B, representative
images of retinal whole mounts stained with Iba-1 of WT, miR-155/, iCCN1/, and miR-155//iCCN1/mice. B and C, double-staining (Iba-1 in
green and IB4 in red) or retinal whole mounts illustrate the relationship between microglia and vasculature in the developing mouse retina at P4. Note
the abundance of microglia at sites of contact between neighboring endothelial tip cells at the vascular front of miR-155/ mice. Microglia are
positioned at branching points of the excessively anastomosed superficial capillary plexus of the largely anastomosed vasculature of iCCN1/ and
miR-155//iCCN1/mice.D, microglial cell count per surface unit of retina of WT, miR-155/, iCCN1/, andmiR-155//iCCN1/mice. *, p	
0.05 versus WT (n  6). Error bars, S.E.
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the mitochondrial translocator protein (TSPO), a selective
marker of microglia in their highly reactive state (43), and
DNAX activation protein of 12 kDa (DAP12), a proinflamma-
tory adaptor protein (44), were down-regulated in miR-155-
deficient mouse retina, whereas CD200R, which triggers an
inhibitory intracellular signaling cascade that blocks proin-
flammatory activation in microglial cells (45), was increased by
nearly 28% as compared with wild-type mouse retinas. In
CCN1/ mutant mouse retinas, the expression of TSPO was
increased, whereas that of CD200R was markedly decreased,
suggesting that CCN1 harnesses, in large part, microglial cell
activation. Expression of DAP12 was not affected following
CCN1 inactivation, which indicates selective CCN1 effects on
microglial marker expression. The resting state of microglial
cells in miR-155/ mouse retinas was also associated with
reduced IL-1 and IL-10 expression but no significant altera-
tions of TNF- and IL-6 levels (Fig. 9A). Conversely, IL-1,
IL-6, and IL-10 were remarkably increased in CCN1-deficient
mouse retinas, as compared with wild-type ones, suggesting
that the expression of CCN1 (or suppression of miR-155)
reduced inflammatory cytokines levels in the retina. Further-
more, alterations of inflammatory marker expression were
nearly identical in iCCN1/ and miR-155//iCCN1/
mouse retinas (data not shown). Under ischemic conditions
(i.e. OIR at P17), miR-155 deficiency alone reduced microglial
cell activation markers (e.g. TSPO and DAP12) and inflamma-
tory cytokines (e.g. IL-1 and IL-10) as compared with wild-
type mouse OIR retinas (Fig. 9B). The alteration of IL-1 and
IL-10 levels were reversed in miR-155//siR-CCN1 mouse
retinas, suggesting a specific effect of CCN1 on the expres-
sion of these cytokines. Of note, CD200R expression was
strongly up-regulated in miR-155//siR-CCN1 retinas,
FIGURE 7. Effects of ischemia-induced retinal neovascularization on microglial cell localization and abundance in wild-type (WT) and miR-155/
mice left untreated or injected with siR-CCN1. A–C, representative retinal whole mounts of mice subjected to 5-day hyperoxia and 5-day normoxia and
double-stained with Iba-1 and IB4. Highly magnified areas illustrate the vascular pattern in central areas of retinas and microglial cell distribution. D–I,
microglial cell distribution (D, F, andH) and count (E,G, and I) in the central avascular (1),middle neovascular (2), and vascularizedperipheral (3) zonesofWTand
miR-155/mice left untreated or injected with siR-CCN1. *, p	 0.05; **, p	 0.001 versus zone 1 (n 5). Error bars, S.E.
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suggesting that its expression is either directly or indirectly
regulated by the dual action of CCN1 and miR-155. Func-
tionally, CD200R up-regulation may occur as a compensa-
tory reaction to suppress the inflammatory response associ-
ated with loss of CCN1. Meanwhile, miR-155 deficiency did
not significantly alter IL-6 expression, whereas dual deletion
of miR-155 and CCN1 induced 
3-fold increase of IL-6 as
compared with wild-type OIR mouse retinas, indicating that
IL-6 expression is potentially sensitive to the levels of CCN1
in the tissue.
Discussion
The key findings of this study are that expression of miR-155
or lack thereof has a major impact on the regulation of retinal
vascular homeostasis and remodeling. The matricellular
CCN1, a potent angiogenic protein that is required for proper
FIGURE 8.miR-155 and CCN1 alter microglial cell activation. A, representative images of the retinal vasculature of WTmice pretreated with control miRNA
(Cntl miR) or Syn-miR-155. Whole retinal mounts were stained with either IB4 (red) or IB4 and Iba-1 (green) and show localization of IB4- and Iba-1-positive
microglia at points of sprout fusion and anastomosis. B andD, microglial cell morphology inWT andmiR-155/mice under normoxic conditions or following
OIR. Restingmicroglia inWTmouse retinas exhibit a ramifiedmorphology with a small ovoid body fromwhich three or four primary processes have sprouted
(B). InWTmice exposed to OIR (C), microglia of the superficial layers of the retina (a) were in higher numbers around the vascular tufts. They become activated
by retracting their processes and also appear IB4-positive (b and c). In the deeper layers (d), microglia show nomorphological signs of activation.D, microglial
cells still adopt a resting statemorphology inmiR-155/mouse retinas after OIR. E–G, Western blot analyses of CD68 protein levels in retinal lysates fromWT,
miR-155/, and iCCN1/normoxicmice at P6 and inWT andmiR-155/ treatedwith either scrambled control siRNA (siR-Scrbl) or siR-CCN1 followingOIR.
CD68 protein band intensities were determined by densitometricmeasurements and normalized to that of GAPDH to account for total protein loading (F and
G). **, p	 0.001 versus control/WT. *, p	 0.001 versusWT-OIR (n 3). Error bars, S.E.
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vessel development and repair, is identified as a molecular tar-
get and downstream effector of miR-155. Analysis of mice with
either single or compound deletion formiR-155 andCCN1 evi-
denced a pivotal function of these molecules in modulating the
inflammatory responsewithin the retina by engagingmicroglial
cells to allow for normal vessel morphogenesis and/or normal-
ization of the retinal vasculature under ischemic conditions.
Deregulation of miR-155 has been associated with different
kinds of cancers and cardiovascular and inflammatory diseases
(12). The large number of miR-155 targets identified in differ-
ent tissues and organs suggests that miR-155 controls numer-
ous biological processes in a context- and tissue type-depen-
dent manner (46). Thus far, evidence of the involvement of
miR-155 in vessel development and pathophysiology has
remained scanty. Retinal angiogenesis, an essential component
of postnatal development of the retina and a prerequisite for
proper retinal function, is a complex process involvingmiRNA-
dependent targeted gene activation and/or repression and
modulation of specific cell signaling pathways (3). We found
that miR-155 was expressed at low levels in the retina during
postnatal development of the vasculature. However, constitu-
tive miR-155 deficiency in mice resulted in retinal vascular
alterations, including increased vessel length, reduced vascular
branch point number, and decreasedmicroglial cell population
in the retina. Along these lines, low expression levels of miR-
155 have previously been reported in lymphocytes, macro-
phages, dendritic cells, and progenitor stem cell populations
(23), yet mice deficient in miR-155 showed defects in lympho-
cyte development and generation of B- and T-cell responses in
vivo (15, 47). Thus, even low levels of miR-155 in cells or tissues
may be important in tissue function and/or structure, which
further underscores the need for miR-155 expression to be
stringently regulated.
miR-155 has various roles in different cell types and physio-
logical situations, and individual targets probably make signif-
icant contributions to miR-155 function in various tissues. The
important role of miR-155 in retinal vessel growth and mor-
phogenesis was further evidenced in our study by the formation
of denser and largely anastomosed retinal vessels following
exogenous intravitreal injection of miR-155 mimic. miR-155
has been found to be expressed in endothelial cells and was
shown to regulate hypoxia by targeting the ELK3 gene (48, 49).
Herein, we identified and characterized a direct link between
miR-155 and CCN1, an angiogenic factor largely produced by
vascular cells, wherebymiR-155 can directly repress expression
of CCN1 and impede its function as an angiogenic factor
orchestrating normal vessel growth and patterning. miR-155
directly interacts with the 3-UTR of the CCN1 gene and
enhanced the repressive effects of the 3-UTR by more than
70%. The 3-UTR-mediated post-transcriptional gene regula-
tion is critical forCCN1 gene expression duration and silencing,
whereas promoter-mediated transcriptional activation of the
CCN1 gene is important for gene induction. Consistent with
our data, a study by Nakagawa et al. (50) revealed that regula-
tory elements that include themiR-155 binding site in the prox-
imal half of the 3-UTR of theCCN1 gene form a stable second-
ary stem-loop structure required for posttranscriptional
regulation of the CCN1 gene. Although several putative targets
of miR-155 have been predicted through bioinformatic and
proteomic approaches, our data showed that knockdown of
CCN1 can mimic many of the effects of miR-155 gain of func-
tion. The delivery of miR-155 mimic, which concomitantly
reduced CCN1 levels in the retina, caused the formation of
hyperplastic and largely anastomosed vessels as a result of
increased growth of endothelial cells. Similarly, deletion
of CCN1 caused retinal vessels to coalesce into large flat hyper-
plastic sinuses with subsequent loss of their hierarchical orga-
nization into arteries, capillaries, and veins, which recapitulates
endothelium-specific loss of CCN1 (35). A study by Roitbak et
al. (48) has demonstrated that interference with miR-155 in
endothelial cells significantly enhances capillary tube forma-
tion, including the number of tubule branch points and tubular
length. Interestingly, the direct effects of recombinant CCN1
on capillary tube formation recapitulate those of miR-155 inhi-
bition (20, 51). The CCN1 protein regulates several aspects of
endothelial cell function, including adhesion, migration, prolif-
eration, and survival. Many of these activities derive from
CCN1 interaction with integrin receptors localized in each of
the CCN1 protein constitutive domains, which contain binding
FIGURE 9.miR-155- and CCN1-dependent regulation of microglial mark-
ers and inflammatory cytokine during development and in response to
OIR. A, gene expression of microglial markers TSPO; DAP12; CDC200R; and
inflammatory cytokines TNF-, IL-1 , IL-6, and IL-10 was quantified by real-
time PCR in retinal lysates from P5 WT and miR-155/ and iCCN1/
mutantmice. The data shown are themeans S.E. (error bars) of three deter-
minations each performed in triplicate. *, p	 0.05 versus control. **, p	 0.01
versus control. B, gene expression of microglial markers and inflammatory
cytokines in WT, miR-155/, and miR-155//siR-CCN1 mice at P17 follow-
ing OIR. The transcript levels were determined by qPCR and normalized to
those of acidic ribosomal phosphoprotein levels. Transcript levels in miR-
155/were comparedwith those inWTmice subjected toOIR and represent
the average of three determinations (n 3). *, p	 0.05; **, p	 0.001.
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sites bearing structural homologies to v3, v5, and 23
integrin binding sequences (52). However, these biological
activities are context-specific and depend on the interaction of
the CCN1 protein with other growth factors and/or receptors
(53, 54, 55). In vivo studies using mouse genetics have demon-
strated that CCN1 activity is integrated with VEGF receptor 2
activation and downstream signaling pathways required for
tubular network formation (35).
Our study design further demonstrated the importance of
microglia in mediating the action of miR-155 and CCN1 on
vessel patterning and morphogenesis. Homeostatic microglia
function to control developmental apoptosis, phagocytosis of
cell debris, shaping of neuronal connections, and guidance of
primary vessel growth (56, 57). Loss of CCN1 expression or
negative regulation of CCN1 by miR-155 altered resident
microglia recruitment, distribution, and reactivity in the retina.
miR-155 deletion was associated with 15% reduction of the
number of microglia, the majority of which exhibited a non-
reactive morphology. Conversely, CCN1 deficiency was associ-
ated with a 35% increase of the number of microglia. Microglial
cells invade the retina around embryonic day 16 and are first
located at the vitreo-retinal surface close to blood vessels (38).
Microglial reactivity is characterized by increasing soma swell-
ing, retraction of protrusions, and generalized disturbance of
the microglial network (58). The number of amoeboid phago-
cytic microglia is the highest around P5, the time point when
ganglion cell death peaks in the retina (59). This is consistent
with their involvement in phagocytosis of dying neurons before
they occupy their strategic positions in both plexiform layers of
the adult retina. Concomitant with a reduced number of amoe-
boid microglial cells in the outer plexiform layers, the expres-
sion of proinflammatory factors, such as IL-10, IL-1, TSPO,
and DAP12, was significantly decreased in miR-155-deficient
retinas. Conversely, ablation of CCN1 reversed the effects of
miR-155 deletion on the expression of the same cytokines as
well as that of IL-6. Dual deletion of miR-155 and CCN1 reca-
pitulated the vascular phenotype associated with CCN1 dele-
tion during development. Thus, miR-155 knock-out andCCN1
re-expression reduced the inflammatory load and microglial
activation in the retina, in agreement with other studies that
have shown that miR-155 is one of the most influential miRNA
of proinflammatory pathways (60).
During vascular development, retinal microglial cells have a
unique spatial relationship with angiogenic tip cells, which
appear in close contact with microglial cells at the point of
turning and branching. Reduced microglial cell count in miR-
155/ mouse retinas is consistent with the formation of a
sparser superficial capillary plexus. Conversely, increased vas-
cular density and anastomosis of the superficial capillary plexus
in iCCN1/mice is consistent with increasedmicroglial cell
number and reactivity, which reflects enhanced angiogenesis
and/or defective remodeling. How miR-155 expression and/or
CCN1 deficiency affect microglial cell-dependent regulation of
vascular density and vascular traffic direction remains to be
elucidated. A study by Stefater et al. (61) has shown that retinal
microglial cells modulates vessel network formation directly by
producing VEGF inhibitory receptor Flt1 through non-canon-
ical Wnt ligands. Interestingly, CCN1 regulates both the
expression of and cell response to Wnt signaling components
(33, 62). Conceptually, CCN1might reduce the signaling sensi-
tivity threshold for the Wnt-Flt1 pathway in microglial cells as
the sprouting process occurs in the retina, although the possi-
bility of more complex pathways involving other cell types as
intermediates cannot be excluded. Future studies will use mice
with compound gene deletion to determine whether and how
paracrine stimulation of microglial cells by CCN1 might mod-
ulate autocrine stimulation of myeloid Wnt ligands.
The connection between miR-155 and CCN1 has relevant
implications for not only physiological angiogenesis but also
retinal vascular pathophysiology, such as retinopathy. OIR is a
common non-diabetic model to study VEGF-dependent neo-
vascularization resulting from ischemia (63). Our data showed
a good correlation between the neovascular growth caused by
OIR and miR-155 expression and down-regulation of CCN1
gene expression. IncreasedmiR-155 levels were associatedwith
the formation of neovascular tufts that grow abnormally into
the avascular vitreous with a simultaneous increase of inflam-
matory factor expression and reactive microglial cells in the
avascular and neovascular areas of the retina. The neovascular
tufts formed consist of poorly perfused immature vessels lack-
ing NG2-positive pericyte coverage (64). This vascular pheno-
type, at least in part, phenocopied retinal vasculature features
upon CCN1 or CCN1 and miR-155 deletion. An extensive
amount of reactive amoeboid microglial cells aggregate in and
around neovascular tufts formed midway between the central
avascular and peripheral vascularized areas of the retina. High
VEGF levels around neovascular tufts can potentially support
migration and growth of microglial cells that express VEGF
receptors 1 and 2 (65). Although it is unlikely that microglia
significantly contribute to the overall VEGF production, their
tropism to neovessels could locally affect vessel sprouts and
thereby substantially influence neovascular tuft formation (66).
Of particular interest is the improved vascular recovery (i.e.
reduced vaso-obliteration and neovascular tuft formation) in
miR-155-deficient mice exhibiting a concomitant increase of
CCN1 expression, whereas deletion of bothCCN1 andmiR-155
exacerbated neovascular alterations. Inhibition of CCN1 abro-
gated the retinal vascular phenotype ofmiR-155mice subjected
to OIR, further linking miR-155 to CCN1 during vascular
repair. There are a number of possible explanations that may
account for the ability of CCN1 to reduce the formation of
neovessels. First, CCN1 dampens VEGF receptor 2 activity
through up-regulation and association of Src homology 2
domain-containing protein tyrosine phosphatase-1 (SHP-1)
with the VEGF receptor (35). By inducing the recruitment of
SHP-1 and rapid dephosphorylation ofVEGF receptor 2, CCN1
helps safeguard against an excessive and aberrant neoangio-
genic response. SHP-1 has also been reported as a direct target
of miR-155, which represses SHP-1 expression through direct
3-UTR interactions (67), suggesting that the dual molecular
action of miR-155 and CCN1 on SHP-1 expression and activity
may harmoniously fine tune physiological angiogenesis. Sec-
ond, the expression of CCN1 reduced the inflammatory load in
hypoxic retina, providing a physiological angiogenesis-friendly
environment. DuringOIR,CCN1 expression andmiR-155 sup-
pression define the “on” and “off” status inmicroglial activation,
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which correlate to “amoeboid” and “ramified” morphologies,
respectively. In support of this idea is the observation that
expression of IL-1, which was reported to sustain microglial
activation and promote microvascular injury via the release of
proapoptotic repulsive semaphoring 3A fromneurons (68), was
significantly reduced in the miR-155/mouse retinas follow-
ingOIR. Likewise, the levels of IL-10,which reduces endothelial
cell proliferation in response to hypoxia (69), were diminished
in themutant mice. IL-10 deficiency inmice has been shown to
significantly reduce pathological retinal angiogenesis (69). Not
only did the combined deletion of CCN1 and miR-155 reverse
these effects on IL-1 and IL-10, but it also strikingly increased
the expression of IL-6, which further exacerbates neovascular
growth (70).
Moreover, the effects of the miR-155/CCN1 regulatory axis
on neovascular growth do not preclude a direct physical and/or
functional interaction between CCN1 and other inflammatory
cells, such as macrophages. Macrophages can exhibit both pro-
and antiangiogenic functions based largely on their polariza-
tion by cytokines in the resident tissue microenvironment (71).
Of these cytokines, IL-10 may possess the most significant
influence on the polarization of macrophages and their ability
to regulate angiogenesis in the eye (72). Low levels of IL-10,
which is a characteristic feature of the retinal environment of
miR-155/ mice after OIR, are associated with “classically
activated” macrophage, or M1 macrophage, that displays an
antiangiogenic phenotype. High levels of IL-10 and reduced
levels of TNF- and IL-6, a characteristic feature of the retinal
environment of CCN1/ mice, are associated with “alterna-
tively activated” macrophages or M2 macrophages that are
proangiogenic. In contrast to a previous in vitro study that dem-
onstrated that CCN1 regulates a proinflammatory genetic pro-
gram in murine macrophage in culture through binding to integ-
rin M2 and the heparin sulfate proteoglycan syndecan-4 (73),
the presence of CCN1 in the retinal environment rather polarizes
inflammatory cells toward an antiangiogenic phenotype. These in
vivo biological functions of CCN1 should be dissociated from its
effects in in vitro culturedmacrophages.
Because bothmiR-155 deletion andCCN1 expression exhibit
overlapping functions and regulate critical aspects of patholog-
ical angiogenesis, therapeutic manipulation of their interaction
represents a potential strategy in treating retinal neovascular-
ization in patientswith retinopathy of prematurity, diabetic ret-
inopathy, and other vascular diseases. The identification of
miR-155 and CCN1 as important regulators of microglia acti-
vation and deactivation also suggests roles for these molecular
effectors in other inflammatory diseases.
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